Editorial: Taking medical advice

Richard Jory
07 Dec 2010

Tweet
Facebook
LinkedIn
Save this article
Send to
Print this page

The structured products industry is home to so many debates that it can sometimes give you a headache. Are the products complex? Should they be treated like any other investment? Are they like cars? Do they ‘do what they say on the tin'? Should grandmothers be allowed to buy them?

All good questions for financial regulators, but are the watchdogs the ones best equipped to come up with the answers and create appropriate legislation? Surely retail investors would be better served by legislators

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to print this content. Please contact [email protected] to find out more.

You are currently unable to copy this content. Please contact [email protected] to find out more.

You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]

You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]